Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

for
Parkinson Disease
Location: Boston MA
Sponsor: Jeffrey S. Schweitzer, MD, PhD

Sex: All

Age: 45 - 70+

Code: NCT06687837

Phase 1, Recruiting

Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

for
Multiple Myeloma
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18 - 60

Code: NCT00800059

Phase 1, Phase 2, Recruiting

Stem Cell Study in Osteoarthritis of the Knee and Hip Joints

for
Osteoarthritis
Location: Brampton
Sponsor: Grigory Karmy

Sex: All

Age: 18 - 70+

Code: NCT05507099

Phase 2, Recruiting

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

for
B-cell Lymphoma, Burkitt Lymphoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 12 - 70

Code: NCT04491370

Phase 1, Phase 2, Recruiting

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

for
Hematologic Malignancy, Solid Tumor, Sickle Cell Disease,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 8+

Code: NCT06689800

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Stem Cells Found in the Abdominal Cavity in Humans

for
Intra-abdominal Surgery
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18 - 60

Code: NCT00576264

Recruiting

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

for
Hematologic Neoplasms
Location: St. John's, Ottawa, St. Catharines, Hamilton, London,
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT04448184

Phase 3, Recruiting

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

for
Dry Age-Related Macular Degeneration, Geographic Atrophy
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)

Sex: All

Age: 55 - 70+

Code: NCT04339764

Phase 1, Phase 2, Recruiting

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

for
Hematologic Malignancies
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07359859

Phase 2, Recruiting

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Rochester NY
Sponsor: Omar Aljitawi

Sex: All

Age: 18 - 70+

Code: NCT03964506

Early Phase 1, Recruiting

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

for
Univentricular Heart, Congenital Heart Disease,
Location: Rochester MN
Sponsor: HeartWorks, Inc.

Sex: All

Age: 18 - 40

Code: NCT05647213

Phase 1, Recruiting

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

for
Hematologic Malignancies
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 60

Code: NCT06807606

Phase 2, Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

for
GATA2, Immunodeficiency, MDS
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 6 - 70

Code: NCT01861106

Phase 2, Recruiting

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

for
Idiopathic CD4-Positive, T-Lymphocytopenia
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT02015013

Phase 2, Recruiting

Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients

for
Malignant Hematologic Neoplasm
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 18 - 70+

Code: NCT04024618

Recruiting

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

for
Myeloid Malignancy
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 18 - 70+

Code: NCT03850418

Phase 2, Recruiting

Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

for
Blood and Marrow Transplant (BMT)
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 0 - 18

Code: NCT01629017

Recruiting

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

for
Covid19
Location: Brandon FL, Sarasota FL, Tulsa OK, Mesquite TX,
Sponsor: Sorrento Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04905836

Phase 2, Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

for
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome)
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 4 - 70+

Code: NCT01174108

Phase 2, Recruiting

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

for
Multiple Myeloma
Location: Detroit MI, Lansing MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT06107738

Phase 2, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial